Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinoma

The Lancet Oncology

Volumn 13, Issue 12, 2012, Pages

  Leusink, Frank K J ^a   van Es, Robert J J ^a   de Bree, Remco ^b   de Jong, Robert J Baatenburg ^c   van Hooff, Sander R ^a   Holstege, Frank C P ^a   Slootweg, Piet J ^d   Brakenhoff, Ruud H ^b   Takes, Robert P ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; GENE EXPRESSION PROFILING; HUMAN; LYMPH NODE METASTASIS; MOLECULAR DIAGNOSIS; MOUTH SQUAMOUS CELL CARCINOMA; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PALPATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CARCINOMA, SQUAMOUS CELL; HUMANS; LYMPHATIC METASTASIS; MOUTH NEOPLASMS; NECK; SENTINEL LYMPH NODE BIOPSY; TRANSCRIPTOME;

EID: 84870185447     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70395-9     Document Type: Note

References (67)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010, 363:24-35.
3. Leemans CR, Braakhuis BJ, Brakenhoff RH The molecular biology of head and neck cancer. Nat Rev Cancer 2011, 11:9-22.
4. Morris LG, Patel SG, Shah JP, Ganly I High rates of regional failure in squamous cell carcinoma of the hard palate and maxillary alveolus. Head Neck 2011, 33:824-830.
5. Montes DM, Carlson ER, Fernandes R, et al. Oral maxillary squamous carcinoma: an indication for neck dissection in the clinically negative neck. Head Neck 2011, 33:1581-1585.
6. Brown JS, Bekiroglu F, Shaw RJ, Woolgar JA, Rogers SN Management of the neck and regional recurrence in squamous cell carcinoma of the maxillary alveolus and hard palate compared with other sites in the oral cavity. Head Neck 2012, published online Feb 6. 10.1002/hed.22957.
7. Argiris A, Karamouzis MV, Raben D, Ferris RL Head and neck cancer. Lancet 2008, 371:1695-1709.
8. Ferlito A, Silver CE, Rinaldo A Elective management of the neck in oral cavity squamous carcinoma: current concepts supported by prospective studies. Br J Oral Maxillofac Surg 2009, 47:5-9.
9. van Wilgen CP, Dijkstra PU, van der Laan BF, Plukker JT, Roodenburg JL Morbidity of the neck after head and neck cancer therapy. Head Neck 2004, 26:785-791.
10. van Wouwe M, de Bree R, Kuik DJ, et al. Shoulder morbidity after non-surgical treatment of the neck. Radiother Oncol 2009, 90:196-201.
11. Bradley PJ, Ferlito A, Silver CE, et al. Neck treatment and shoulder morbidity: still a challenge. Head Neck 2011, 33:1060-1067.
12. Nieuwenhuis EJ, Castelijns JA, Pijpers R, et al. Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node?. Head Neck 2002, 24:282-289.
13. Rodrigo JP, Shah JP, Silver CE, et al. Management of the clinically negative neck in early-stage head and neck cancers after transoral resection. Head Neck 2011, 33:1210-1219.
14. Weiss MH, Harrison LB, Isaacs RS Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 1994, 120:699-702.
15. de Bondt RB, Nelemans PJ, Hofman PA, et al. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 2007, 64:266-272.
16. Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst 2008, 100:712-720.
17. Ng SH, Yen TC, Chang JT, et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 2006, 24:4371-4376.
18. Buckley JG, MacLennan K Cervical node metastases in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution. Head Neck 2000, 22:380-385.
19. Liao LJ, Lo WC, Hsu WL, Wang CT, Lai MS Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities. BMC Cancer 2012, 12:236.
20. Takes RP, Rinaldo A, Rodrigo JP, Devaney KO, Fagan JJ, Ferlito A Can biomarkers play a role in the decision about treatment of the clinically negative neck in patients with head and neck cancer?. Head Neck 2008, 30:525-538.
21. Melchers LJ, Schuuring E, van Dijk BA, et al. Tumour infiltration depth >/=4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol 2012, 48:337-342.
22. Pentenero M, Gandolfo S, Carrozzo M Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck 2005, 27:1080-1091.
23. Huang SH, Hwang D, Lockwood G, Goldstein DP, O'Sullivan B Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies. Cancer 2009, 115:1489-1497.
24. Lodder WL, Teertstra HJ, Tan IB, et al. Tumour thickness in oral cancer using an intra-oral ultrasound probe. Eur Radiol 2011, 21:98-106.
25. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
26. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
27. Chung CH, Parker JS, Karaca G, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004, 5:489-500.
28. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
29. Chung CH, Parker JS, Ely K, et al. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-κB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res 2006, 66:8210-8218.
30. Roepman P, Wessels LF, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005, 37:182-186.
31. Roepman P, Kemmeren P, Wessels LF, Slootweg PJ, Holstege FC Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. Cancer Res 2006, 66:2361-2366.
32. van Hooff SR, Leusink FK, Roepman P, et al. Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma. J Clin Oncol 2012, published online Oct 8. 10.1200/JCO.2011.40.4509.
33. Alkureishi LW, Ross GL, Shoaib T, et al. Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol 2010, 17:2459-2464.
34. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003, 95:1772-1783.
35. Ferlito A, Rinaldo A, Devaney KO, Nakashiro K, Hamakawa H Detection of lymph node micrometastases in patients with squamous carcinoma of the head and neck. Eur Arch Otorhinolaryngol 2008, 265:1147-1153.
36. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010, 467:1114-1117.
37. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012, 366:883-892.
38. Nik-Zainal S, Alexandrov LB, Wedge DC, et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012, 149:979-993.
39. Nik-Zainal S, Van Loo P, Wedge DC, et al. The life history of 21 breast cancers. Cell 2012, 149:994-1007.
40. Xie Y, Xiao G, Coombes KR, et al. Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients. Clin Cancer Res 2011, 17:5705-5714.
41. Smeets SJ, Harjes U, van Wieringen WN, et al. To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic!. Clin Cancer Res 2011, 17:4959-4964.
42. Alkureishi LW, Burak Z, Alvarez JA, et al. Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol 2009, 16:3190-3210.
43. Murer K, Huber GF, Haile SR, Stoeckli SJ Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the n0 neck in patients with oral squamous cell carcinoma. Head Neck 2011, 33:1260-1264.
44. Civantos FJ, Zitsch RP, Schuller DE, et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol 2010, 28:1395-1400.
45. Paleri V, Rees G, Arullendran P, Shoaib T, Krishman S Sentinel node biopsy in squamous cell cancer of the oral cavity and oral pharynx: a diagnostic meta-analysis. Head Neck 2005, 27:739-747.
46. Kovacs AF, Stefenelli U, Seitz O, et al. Positive sentinel lymph nodes are a negative prognostic factor for survival in T1-2 oral/oropharyngeal cancer-a long-term study on 103 patients. Ann Surg Oncol 2009, 16:233-239.
47. Broglie MA, Haile SR, Stoeckli SJ Long-term experience in sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Ann Surg Oncol 2011, 18:2732-2738.
48. Gurney BAS, Schilling C, Putcha V, et al. Implications of a positive sentinel node in oral squamous cell carcinoma. Head Neck 2012, published online Jan 31. 10.1002/hed.21973.
49. Haerle SK, Hany TF, Strobel K, Sidler D, Stoeckli SJ Is there an additional value of SPECT/CT over planar lymphoscintigraphy for sentinel node mapping in oral/oropharyngeal squamous cell carcinoma?. Ann Surg Oncol 2009, 16:3118-3124.
50. 89Zr-nanocolloidal albumin-based PET/CT lymphoscintigraphy for sentinel node detection in head and neck cancer: preclinical results. J Nucl Med 2011, 52:1580-1584.
51. Vermeeren L, Valdes Olmos RA, Klop WM, Balm AJ, van den Brekel MW A portable gamma-camera for intraoperative detection of sentinel nodes in the head and neck region. J Nucl Med 2010, 51:700-703.
52. Heuveling DA, Karagozoglu KH, van Schie A, van Weert S, van Lingen A, de Bree R Sentinel node biopsy using 3D lymphatic mapping by freehand SPECT in early stage oral cancer: a new technique. Clin Otolaryngol 2012, 37:89-90.
53. van den Berg NS, Brouwer OR, Klop WM, et al. Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid. Eur J Nucl Med Mol Imaging 2012, 39:1128-1136.
54. Keereweer S, Hutteman M, Kerrebijn JD, van de Velde CJ, Vahrmeijer AL, Lowik CW Translational optical imaging in diagnosis and treatment of cancer. Curr Pharm Biotechnol 2012, 13:498-503.
55. Vorburger MS, Broglie MA, Soltermann A, et al. Validity of frozen section in sentinel lymph node biopsy for the staging in oral and oropharyngeal squamous cell carcinoma. J Surg Oncol 2012, published online May 14. 10.1002/jso.23156.
56. Ferris RL, Xi L, Seethala RR, et al. Intraoperative qRT-PCR for detection of lymph node metastasis in head and neck cancer. Clin Cancer Res 2011, 17:1858-1866.
57. Bar Ad V, Chalian A Management of clinically negative neck for the patients with head and neck squamous cell carcinomas in the modern era. Oral Oncol 2008, 44:817-822.
58. Genden EM, Ferlito A, Silver CE, et al. Contemporary management of cancer of the oral cavity. Eur Arch Otorhinolaryngol 2010, 267:1001-1017.
59. Yuen AP, Ho CM, Chow TL, et al. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck 2009, 31:765-772.
60. Song T, Bi N, Gui L, Peng Z Elective neck dissection or "watchful waiting": optimal management strategy for early stage N0 tongue carcinoma using decision analysis techniques. Chin Med J (Engl) 2008, 121:1646-1650.
61. Okura M, Aikawa T, Sawai NY, Iida S, Kogo M Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol 2009, 45:908-911.
62. Keski-Santti H, Atula T, Tornwall J, Koivunen P, Makitie A Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol 2006, 42:96-101.
63. Tsang RK, Chung JC, Howe To VS, Chan JY, Ho WK, Wei WI Efficacy of salvage neck dissection for isolated nodal recurrences in early carcinoma of oral tongue with watchful waiting management of initial N0 neck. Head Neck 2011, 33:1482-1485.
64. Classe JM, Baffert S, Sigal-Zafrani B, et al. Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer: a national study based on a prospective multi-institutional series of 985 patients 'on behalf of the Group of Surgeons from the French Unicancer Federation'. Ann Oncol 2012, 23:1170-1177.
65. Takes RP, Rinaldo A, Silver CE, et al. Future of the TNM classification and staging system in head and neck cancer. Head Neck 2010, 32:1693-1711.
66. Gerds TA, Cai T, Schumacher M The performance of risk prediction models. Biom J 2008, 50:457-479.
67. Stadler WM Prognosis and prediction in a Facebook world. Cancer 2009, 115:5368-5370.